Attitude of the adult patient with atopic dermatitis to the disease and its treatment: The ACTIDA Study;Actitud del paciente adulto con dermatitis atópica frente a su patología y tratamiento. Estudio ACTIDA

Actas Dermo-Sifiliograficas

Volumn 101, Issue 2, 2010, Pages 143-150

  Betlloch, I ^a   Izu, R ^b   Lleonart, M ^c   Ferrer, M ^d   Ferrando, J ^e  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b HOSPITAL DE BASURTO   (Spain)

^c Departamento Médico   (Spain)

^d ADKNOMA Health Research SL   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

Author keywords

Atopic dermatitis; Patient attitude; Treatment

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; ATOPIC DERMATITIS; DISEASE SEVERITY; DRUG USE; EPIDEMIC; HUMAN; PATIENT ATTITUDE; PRESCRIPTION; QUALITY OF LIFE;

EID: 77649170155     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/j.ad.2009.07.020     Document Type: Article

References (17)

1. Finlay A.Y. Quality of life in atopic dermatitis. J Am Acad Dermatol 45 (2002) S64-S66
2. Kiebert G., Sorensen S.V., Revicki D., Fagan S.C., Doyle J.J., Cohen J., et al. Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol 41 (2002) 151-158
3. Levy M.L. Atopic dermatitis: understanding the disease and its management. Curr Med Res Opin 23 (2007) 3091-3103
4. Williams I.I., Robertson C., Stewart A., Aït-Khaled N., Anabwani G., Anderson R., et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J Allergy Clin Immunol 103 (1999) 125-138
5. Williams H. Epidemiology of atopic dermatitis: recent advances and future predictions. Curr Probl Dermatol 28 (1999) 9-17
6. Williams H. Epidemiology of atopic dermatitis. Clin Exp Dermatol 25 (2000) 522-529
7. Wuthrich B. Clinical aspects, epidemiology and prognosis of atopic dermatitis. Ann Allergy Asthma Immunol 83 (1999) 464-470
8. Correale C.E., Walter C., Murphy L.N., and Graig T.J. Atopic dermatitis: A review of diagnosis and treatment. Am Fam Phys 60 (1999) 1191-1198
9. Méndez-Cabeza J., Alache H., and Cerrada E. Manejo de la dermatitis atópica en Atención Primaria. Medifam 13 (2003) 75-84
10. Baselga E. Tratamiento de la dermatitis atópica en la infancia. Actas Dermosifiliogr 94 (2003) 345-355
11. McAlister R.O., Tofte S.J., Doyle J.J., Jackson A., and Hanifin J.M. Patient and physician perspectives vary on atopic dermatitis. Cutis 69 (2002) 461-466
12. Charman C.R., Venn A.J., Williams H., and Bigby M. Measuring atopic eczema severity visually. Arch Dermatol 141 (2005) 1146-1151
13. Baron E.D., Barzilai D., Johnston G., Kawashima M., Takigawa M., Nakagawa H., et al. Atopic dermatitis management: comparing the treatment patterns of dermatologists in Japan, USA and UK. Br J Dermatol 147 (2002) 710-715
14. Eichenfield L.F., Lucky A.W., Boguniewicz M., Langley R.G.B., Cherill R., Marshall K., et al. Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. J Am Acad Dermatol 46 (2002) 495-504
15. Ellis C., Luger T., on behalf of the ICCAD Faculty: Abeck D, Allen R, Graham-Brown RAC, De Prost Y, Einchenfield LF, Ferrándiz C, et al. International Consensus Conference on Atopic Dermatitis II (ICCAD II*): clinical update and current treatment strategies. Br J Dermatol 148 (2003) 3-10
16. Rudikoff D. Atopic dermatitis-Treatment Update. US Dermatol Rev 1-5 (2006)
17. Barbier N., Paul C., Luger T., Allen R., De Prost Y., Papp K., et al. Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1,550 patients from the pimecrolimus cream 1% randomized controlled trials programme. Br J Dermatol 150 (2004) 90-102